Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
Authors: Kuruvilla et al.
Sci Rep. 2022 Mar 24;12(1):5110.
PMID: 35332216 | PMCID: PMC8948251 | DOI: 10.1038/s41598-022-09071-6
Share this article
Sign Up For An MSC Newsletter
Sign Up for MSC Content Alerts!
Receive immediate notification when a new piece of content is published on MSC! You can sign up for new article alerts, new literature recap alerts, and/or our monthly newsletter. Visit here to sign up.